• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Role of the Endothelium in Severe COVID-19.

作者信息

Brandão Simone Cristina Soares, Godoi Emmanuelle Tenório Albuquerque Madruga, Ramos Júlia de Oliveira Xavier, Melo Leila Maria Magalhães Pessoa de, Dompieri Luca Terracini, Brindeiro Filho Djair Falcão, Sarinho Emanuel Sávio Cavalcanti

机构信息

Universidade Federal de Pernambuco, Recife, PE - Brasil.

Serviço de Hematologia de São José dos Campos, São José dos Campos, SP - Brasil.

出版信息

Arq Bras Cardiol. 2020 Dec;115(6):1184-1189. doi: 10.36660/abc.20200643.

DOI:10.36660/abc.20200643
PMID:33470322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8133713/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/d626fef1cb2e/0066-782X-abc-115-06-1184-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/66fb4845130e/0066-782X-abc-115-06-1184-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/0f0ae51960df/0066-782X-abc-115-06-1184-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/01b9ff9c7563/0066-782X-abc-115-06-1184-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/d626fef1cb2e/0066-782X-abc-115-06-1184-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/66fb4845130e/0066-782X-abc-115-06-1184-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/0f0ae51960df/0066-782X-abc-115-06-1184-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/01b9ff9c7563/0066-782X-abc-115-06-1184-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cf/8133713/d626fef1cb2e/0066-782X-abc-115-06-1184-gf02-en.jpg

相似文献

1
The Role of the Endothelium in Severe COVID-19.内皮细胞在重症新型冠状病毒肺炎中的作用
Arq Bras Cardiol. 2020 Dec;115(6):1184-1189. doi: 10.36660/abc.20200643.
2
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.严重急性呼吸综合征冠状病毒 2 在 COVID-19 死亡患者肺部、气道和血管内皮中的复制和嗜性的证据：一项尸检病例系列研究。
J Infect Dis. 2021 Mar 3;223(5):752-764. doi: 10.1093/infdis/jiab039.
3
In reply-COVID-19: Precision Medicine and Vascular Endothelium.回复——新型冠状病毒肺炎：精准医学与血管内皮
Mayo Clin Proc. 2021 Jun;96(6):1672. doi: 10.1016/j.mayocp.2021.04.006. Epub 2021 Apr 19.
4
COVID-19 Is an Endothelial Disease: Implications of Nitric Oxide.COVID-19 是一种血管内皮疾病：一氧化氮的影响。
Adv Exp Med Biol. 2021;1321:109-113. doi: 10.1007/978-3-030-59261-5_9.
5
Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.回复程等人：2019冠状病毒病诱导的细胞因子程度较低，但通过白细胞介素-6信号通路损害血管内皮。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2105040118.
6
Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together.新冠病毒肺炎及急性感染中的内皮损伤：拼凑谜题
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1774-1776. doi: 10.1161/ATVBAHA.121.316101. Epub 2021 Apr 1.
7
[Impairment of the microculation in COVID-19].[新型冠状病毒肺炎中的微循环障碍]
Med Klin Intensivmed Notfmed. 2021 Sep;116(6):530-534. doi: 10.1007/s00063-021-00842-z. Epub 2021 Aug 10.
8
Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium.新冠肺炎疾病严重程度的患者个体差异。主要怀疑对象：血管内皮。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2540-2541. doi: 10.1016/j.jaip.2021.02.063.
9
Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium".对《2019冠状病毒病严重程度的患者个体差异。主要怀疑对象：血管内皮》的回复
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2541-2542. doi: 10.1016/j.jaip.2021.03.031.
10
COVID-19 and the endothelium.COVID-19 与血管内皮。
Clin Hemorheol Microcirc. 2020;75(1):7-11. doi: 10.3233/CH-209007.

引用本文的文献

1
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.在实验性新冠肺炎中，赖诺普利可提高肺部血管紧张素转换酶2（ACE2）水平和严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量，并减轻炎症，但不会降低疾病严重程度。
Front Pharmacol. 2024 Jul 12;15:1414406. doi: 10.3389/fphar.2024.1414406. eCollection 2024.
2
Predictors of mortality in critically ill patients with COVID-19 and diabetes.COVID-19 合并糖尿病危重症患者的死亡预测因素。
Braz J Med Biol Res. 2023 Aug 14;56:e12728. doi: 10.1590/1414-431X2023e12728. eCollection 2023.

本文引用的文献

1
Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.新型冠状病毒肺炎与脑卒中：临床特征与病理生理学见解。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941. Epub 2020 May 12.
2
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.肝素与严重急性呼吸综合征相关冠状病毒 2（SARS-CoV-2）刺突糖蛋白结合相互作用的表征。
Antiviral Res. 2020 Sep;181:104873. doi: 10.1016/j.antiviral.2020.104873. Epub 2020 Jul 10.
3
Extrapulmonary manifestations of COVID-19.
COVID-19 的肺外表现。
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
4
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.2020 年新型冠状病毒病（COVID-19）患者抗栓治疗的循证实用指南。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936350. doi: 10.1177/1076029620936350.
5
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素：前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
6
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
7
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.SARS-CoV-2 的受体 ACE-2 在许多不同的细胞类型上表达：对基于 ACE 抑制剂和血管紧张素 II 受体阻滞剂的心血管治疗的影响。
Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19.
8
Advances in the relationship between coronavirus infection and cardiovascular diseases.冠状病毒感染与心血管疾病关系的研究进展。
Biomed Pharmacother. 2020 Jul;127:110230. doi: 10.1016/j.biopha.2020.110230. Epub 2020 May 13.
9
COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction.新冠病毒病作为一种心血管疾病：慢性内皮功能障碍的潜在作用
Cardiovasc Res. 2020 Aug 1;116(10):e132-e133. doi: 10.1093/cvr/cvaa140.
10
The Heart and COVID-19: What Cardiologists Need to Know.《心脏与 COVID-19：心脏病学家须知》。
Arq Bras Cardiol. 2020 May 11;114(5):805-816. doi: 10.36660/abc.20200279.